PharmExec Direct eNewsletter

PharmExec Direct:
Having trouble viewing this e-mail? Click here.

You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile

PharmExec Direct | From the editors of Pharmaceutical Executive

July 15, 2010 | ISSUE NUMBER 156 VOL 8

Advisory
Judgment Day for Avandia
The big day arrived on Wednesday for GSK’s controversial diabetes drug—FDA decided whether or not to pull Avandia from the market.

Advertisement:
Are You Really Closing the Loop?
There is a considerable advantage to being one of the first companies in pharma to successfully close the loop and pave the way to a new commercial model that puts the customer first. However, implementing comprehensive, closed-loop marketing has proven difficult for many in our industry. Capgemini Consulting examines the functional implications for implementing closed-loop marketing across the commercial organization and the hurdles to overcome to fully close the loop. Click Here Click Here

Moving On + Up
PhRMA Announces Billy Tauzin’s Successor
John Castellani received the nod from PhRMA on Tuesday to take over the role of president and CEO in September.

Regulatory
FDA to Weigh In on Obesity Drug
Vivus’s weight-loss drug Qnexa is heading into an FDA review with the backing of generally positive study data. Will FDA give the thumbs up? Depends on how severe it thinks the side effects are.

Global
The Bizarre European Political Bazaar
Pharm Exec Europe’s Brussels correspondent Reflector is exasperated by some of the European Union’s more unusual institutional arrangements.

In The Magazine
Crackdown on Counterfeits
FDA and industry seek to ensure drug quality in a world complicated by global outsourcing and theft.

Lafmin Morgan joined Talecris Biotherapeutics as VP of US product management. // Ikaria hired Craig Tooman as SVP and CFO. // Hycor Biomedical appointed Richard Hockins VP of sales and marketing. // NewLink Genetics added Joseph Saluri to its board. // Biovista appointed Clifford Farrah to its advisory board.

Jul 26–27 Bio/Pharmaceutical Summit: Optimize Market Research and to Drive Accurate Product Forecasts
Philadelphia, PA

Jul 29–30 5th Annual Congress on Clinical Supply Chain Management
Princeton, NJ

Sep 9–10 Clinical Trials in Latin America
Lima, Peru

Sep 29–30 6th Annual Bio/Pharmaceutical and Medical Device Product Recalls Summit
Washington, DC

Dec 8—9 CMAC 2010 - Commercialization and Market Access Congress
Orlando, FL

If you plan to enter emerging markets over the next 3 years, what will be your primary entry strategy?

UK Announces NHS Overhaul Plans

Synta Pharma CEO Trumpets New Top Cancer Drug

The Shrinking Pharma Labor Force

Johnson & Johnson acquires Micrus Endovascular


	Follow Pharm Exec on Twitter
	Follow Pharm Exec on Facebook

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.